Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 801–900 of 1,005
Tumor microenvironment metabolites directing T cell differentiation and function
Liu, X., Hoft, D. F., & Peng, G. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.12.004 · Cited by 49
Diet, nutrient supply, and tumor immune responses
McIntyre, C., Temesgen, A., & Lynch, L. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.003 · Cited by 46
Altered cancer metabolism and implications for next-generation CAR T-cell therapies
Ramapriyan, R., Vykunta, V. S., Vandecandelaere, G., Richardson, L. G., Sun, J. M., Curry, W. T., & Choi, B. D. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108667 · Cited by 49
Sasaki, C. Y., Chen, G., Munk, R. B., Eitan, E., Martindale, J. L., Longo, D. L., & Ghosh, P. (2015) · European Journal of Immunology · doi:10.1002/eji.201445422 · Cited by 48
Understanding the tumour micro‐environment communication network from an NOS2/COX2 perspective
Basudhar, D., Bharadwaj, G., Somasundaram, V., Cheng, R. Y. S., Ridnour, L. A., Fujita, M., Lockett, S., Anderson, S. K., McVicar, D. W., & Wink, D. A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14488 · Cited by 47
“Naïve T-cells, memory CD8 and Tregs also rely on fatty acid oxidation for their energy requirements (Michalek et al., 2011; van der Windt et al., 2012).”
BackgroundDaneshmandi, S., Cassel, T., Higashi, R. M., Fan, T. W. ‐., & Seth, P. (2021) · eLife · doi:10.7554/elife.67476 · Cited by 43
Obesity-associated cancer: an immunological perspective
Conroy, M. J., Dunne, M. R., Donohoe, C. L., & Reynolds, J. V. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115004176 · Cited by 48
“Following resolution of the immune response, the remaining pool of memory T cells mainly utilise OxPhos and lipid oxidation to meet their lower turnover rates and to support their longevity, as do Treg cells((147,148)).”
BackgroundFree radicals and redox signalling in T-cells during chronic inflammation and ageing
Griffiths, H. R., Dunston, C. R., Bennett, S. J., Grant, M. M., Phillips, D. C., & Kitas, G. D. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391273 · Cited by 42
Yero, A., Bouassa, R. M., Ancuța, P., Estaquier, J., & Jenabian, M.-A. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.01.001 · Cited by 47
Nutrient inputs and social metabolic control of T cell fate
Bacigalupa, Z. A., Landis, M. D., & Rathmell, J. C. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.009 · Cited by 48
Self-citationWang, J., Zhang, W., Liu, C., Wang, L., Wu, J., Sun, C., & Wu, Q. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.92125 · Cited by 56
“For instance, effector T-cells exhibit elevated levels of FA production, whereas Tregs exhibit increased lipolysis and lipid oxidation [153, 154].”
BackgroundZhao, X., Zhang, J., Li, C., Kuang, W., Deng, J., Tan, X., Li, C., & Li, S. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101975 · Cited by 50
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
Zarrouk, M., Finlay, D. K., Foretz, M., Viollet, B., & Cantrell, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106710 · Cited by 46
“T cells [12–14].”
The Immune System in Obesity: Developing Paradigms Amidst Inconvenient Truths
Agrawal, M., Kern, P. A., & Nikolajczyk, B. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0917-9 · Cited by 48
Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells
Lee, G. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/5458178 · Cited by 53
Zinser, M. E., Highton, A. J., Kurioka, A., Kronsteiner, B., Hagel, J., Leng, T., Marchi, E., Phetsouphanh, C., Willberg, C. B., Dunachie, S. J., et al. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12020 · Cited by 45
“Recognition of cognate antigen during an immune response by na€ıve T cells switches them from a metabolically quiescent state, preferentially using oxidative phosphorylation for ATP production, to a more active state, predominantly reliant upon the use of aerobic glycolysis.(10) Once the antigen is cleared, “metabolic…”
BackgroundCelastrol mediates Th17 and Treg cell generation via metabolic signaling
Zhang, J., Shan, J., Chen, X., Li, S., Long, D., & Li, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.163 · Cited by 44
The role of metabolic reprogramming in T cell fate and function.
Patsoukis, N., Bardhan, K., Weaver, J. D., Herbel, C., Seth, P., Li, L., & Boussiotis, V. A. (2016) · PubMed · Cited by 56
Sim, S. W., Weinstein, D. A., Lee, Y., & Jun, H. S. (2019) · FEBS Letters · doi:10.1002/1873-3468.13666 · Cited by 49
Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease
Hippen, K. L., Aguilar, E. G., Rhee, S. Y., Bolivar-Wagers, S., & Blazar, B. R. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.005 · Cited by 45
“In contrast, murine and human iTregs are more dependent on OXPHOS than tTRegs [35, 36].”
BackgroundB cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis
Zeng, Q., Yuan, W., Lao, X., Chen, D., Huang, C.-X., Lin, Q., He, M. Y., Liao, Y., Zheng, L., Li, B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb6296 · Cited by 45
“It is known that effector and inflammatory TH subsets require glycolysis, whereas memory and regulatory T cells depend on oxidative phosphorylation and fatty acid metabolism (16, 17).”
Xia, Y., Brown, Z. J., Huang, H., & Tsung, A. (2021) · Cancer Medicine · doi:10.1002/cam4.4177 · Cited by 48
Tian, M., Hao, F., Jin, X., Sun, X. J., Jiang, Y., Wang, Y., Li, D., Chang, T., Zou, Y., Peng, P., et al. (2021) · eLife · doi:10.7554/elife.62394 · Cited by 44
“Unlike effector T cells, including Th1, Th2, and Th17, which ‘prefer’ FAS, iTreg cells ‘favor’ FAO (Maciolek et al., 2014; Michalek et al., 2011; Wang et al., 2011).”
BackgroundResultInfluentialManipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen, C., Wang, Z., Ding, Y., & Qin, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1090429 · Cited by 49
Lipid peroxidation of immune cells in cancer
Xiao, L., Xian, M., Zhang, C., Guo, Q., & Yi, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1322746 · Cited by 58
Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling
Gülow, K., Tümen, D., Heumann, P., Schmid, S. A., Kandulski, A., Müller, M., & Kunst, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116114 · Cited by 50
Mitochondrial and cytosolic roles of PINK 1 shape induced regulatory T‐cell development and function
Ellis, G. I., Zhi, L., Akundi, R. S., Büeler, H., & Martí, F. (2013) · European Journal of Immunology · doi:10.1002/eji.201343571 · Cited by 42
Wasinski, F., Gregnani, M. F., Ornellas, F. H., Bacurau, A. V. N., Câmara, N. O. S., Araújo, R. C., & Bacurau, R. F. P. (2014) · Mediators of Inflammation · doi:10.1155/2014/326803 · Cited by 51
Mapping Lupus Susceptibility Genes in the NZM2410 Mouse Model
Morel, L. M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00004-7 · Cited by 40
Early changes in the metabolic profile of activated CD8+ T cells
Cammann, C., Rath, A., Reichl, U., Lingel, H., Brunner-Weinzierl, M. C., Simeoni, L., Schraven, B. L., & Lindquist, J. A. (2016) · BMC Cell Biology · doi:10.1186/s12860-016-0104-x · Cited by 46
“Previous studies revealed an important role of mTOR in the regulation of differentiation into CD4+ T cell subsets like Th1, Th2 and Th17 cells [34, 35].”
Layman, A. A. K., Deng, G., O’Leary, C. E., Tadros, S., Thomas, R. M., Dybas, J. M., Moser, E. K., Wells, A. D., Doliba, N. M., & Oliver, P. M. (2017) · Nature Communications · doi:10.1038/ncomms15677 · Cited by 46
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
Hefazi, M., Bolivar-Wagers, S., & Blazar, B. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189676 · Cited by 43
das Neves, M. F., Batuca, J. R., & Alves, J. D. (2021) · Immunology · doi:10.1111/imm.13348 · Cited by 42
“Tregs differ from other lymphocytes in its metabolic requirements, as they rely mostly on lipids as the source of energy to survive.[94,95] Treg counts increase in the presence of HDL at physiological concentrations, in a dosedependent manner, with a decrease in the percentage of apoptotic Treg, suggesting that HDL pr…”
BackgroundMetabolic advantages of regulatory T cells dictated by cancer cells
Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 44
Glycolysis: A fork in the path of normal and pathological pregnancy
Gou, R., & Zhang, X. (2023) · The FASEB Journal · doi:10.1096/fj.202301230r · Cited by 43
“118,119 By contrast, memory T cells rely mainly on fatty acid oxidation and OXPHOS, whereas terminally exhausted T cells depend primarily upon glycolysis for their energy supply.”
BackgroundImmunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications
Chen, Y., Lin, Q., Cheng, H., Xiang, Q., Zhou, W., Wu, J., & Wang, X. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103738 · Cited by 45
Immunometabolism of regulatory T cells in cancer
Saravia, J., & Chi, H. (2025) · Oncogene · doi:10.1038/s41388-025-03458-1 · Cited by 52
“As compared with effector CD4 + T cells, T reg cells are less dependent on glycolysis and instead rely upon mitochondrial oxidative phosphorylation (OXPHOS) to produce energy [53 – 55], and these metabolic characteristics are regulated by FOXP3 [56].”
T cell metabolism and the immune response
Verbist, K., Wang, R., & Green, D. R. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.006 · Cited by 46
Computational modeling of heterogeneity and function of CD4+ T cells
Carbo, A., Hontecillas, R., Andrew, T., Eden, K. B., Mei, Y., Hoops, S., & Bassaganya-Riera, J. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00031 · Cited by 57
“In fact, effector and regulatory phenotypes have distinct glycolytic and lipid oxidative metabolic programs (Michalek et al., 2011).”
BackgroundAlteration of cellular metabolism in cancer cells and its therapeutic prospects
Biswal, B. N., Das, S., Das, B., & Rath, R. (2017) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_60_17 · Cited by 62
“[95] Like the cancer cells, rapidly proliferating cells of immune system rely on aerobic glycolysis[96-98] and glutamine metabolism.”
BackgroundmTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation
Gedaly, R., Stefano, F. D., Turcios, L. M., Hill, M., Hidalgo, G. E., Mitov, M. I., Alstott, M. C., Butterfield, D. A., Mitchel, H., Hart, J., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002495 · Cited by 43
Kim, Y., Kumar, A., Chang, C., & Pyaram, K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700567 · Cited by 45
Immunometabolism in the pathogenesis of systemic lupus erythematosus
Zhang, C., Wang, H., Yin, L., Mao, Y., & Zhou, W. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100046 · Cited by 46
Mechanisms of TREG cell adaptation to inflammation
Alvarez, F., Al-Aubodah, T.-A., Yang, Y. H., & Piccirillo, C. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr0120-196r · Cited by 46
Hosomi, K., & Kunisawa, J. (2020) · International Immunology · doi:10.1093/intimm/dxaa020 · Cited by 43
Metabolic Fitness of T Cells in Autoimmune Disease
Wu, B., Goronzy, J. J., & Weyand, C. M. (2020) · Immunometabolism · doi:10.20900/immunometab20200017 · Cited by 39
“In contrast, regulatory T cells and memory T cells depend mostly on fatty acid oxidation [7,10] to support their survival needs and their functional activities.”
BackgroundZhao, L., Wu, Q., Wang, X., Wang, S., Shi, X., Shan, Z., & Teng, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.659738 · Cited by 225
Immune Metabolism of IL-4-Activated B Cells and Th2 Cells in the Context of Allergic Diseases
Lin, Y., Goretzki, A., & Schülke, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790658 · Cited by 44
Yang, W., Yu, T., & Cong, Y. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac018 · Cited by 46
An interferon gamma response signature links myocardial aging and immunosenescence
Ashour, D., Rebs, S., Arampatzi, P., Saliba, A.-E., Dudek, J., Schulz, R., Hofmann, U., Frantz, S., Cochain, C., Streckfuß-Bömeke, K., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad068 · Cited by 39
“29,30 In order to track whether such metabolic shifts are observed in the aging mediastinal lymph node T cells, we made use of compiled gene scores for oxidative phosphorylation (OxPhos), fatty acid oxidation (FAO), and glycolysis for T cells across the different age groups.”
MethodVaikunthanathan, T., Landmann, E., Marin-Correa, D., Romano, M., Trevelin, S. C., Peng, Q., Crespo, E., Corrado, M., Lozano, J. J., Pearce, E. L., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104778 · Cited by 43
“61,73 In this regard, a previous study identi fi ed oxidative-mediated mitochondrial damage as a mechanism of Treg dysfunction in patients with autoimmunity.”
BackgroundSubset-specific mitochondrial stress and DNA damage shape T cell responses to fever and inflammation
Heintzman, D. R., Sinard, R. C., Fisher, E. L., Ye, X., Patterson, A. R., Elasy, J. H., Voss, K., Chi, C., Sugiura, A., Rodriguez-Garcia, G. J., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adp3475 · Cited by 47
Self-citationLiu, A.-B., Tan, B., Yang, P., Tian, N., Li, J., Wang, S.-C., Yang, L., Ma, L., & Zhang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1487576 · Cited by 56
Singh, A., & Chaudhary, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114616 · Cited by 44
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma
Liang, C., Qin, Y., Zhang, B., Ji, S., Shi, S., Xu, W., Liu, J., Xiang, J., Liang, D., Hu, Q., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.09.001 · Cited by 41
Schmoch, T., Uhle, F., Siegler, B. H., Fleming, T., Morgenstern, J., Nawroth, P. P., Weigand, M. A., & Brenner, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030657 · Cited by 40
The Oxidative State of Cysteine Thiol 144 Regulates the SIRT6 Glucose Homeostat
Long, D. L., Wu, H., Tsang, A. W., Poole, L. B., Yoza, B. K., Wang, X., Vachharajani, V., Furdui, C. M., & McCall, C. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-11388-6 · Cited by 39
Recipe for IBD: can we use food to control inflammatory bowel disease?
Witkowski, M., Witkowski, M., Gagliani, N., & Huber, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0658-5 · Cited by 44
“Compared to effector Tcells, such as TH17 cells, which are reliant on glucose metabolism, the generation of regulatory CD4 Tcells has been shown to be selectively dependent on lipid oxygenation [80].”
BackgroundImmune Cells Gate White Adipose Tissue Expansion
Cox, A. R., Chernis, N., Masschelin, P. M., & Hartig, S. M. (2019) · Endocrinology · doi:10.1210/en.2019-00266 · Cited by 42
Metabolic regulation of pathogenic autoimmunity: therapeutic targeting
Teng, X., Cornaby, C., Li, W., & Morel, L. M. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.07.001 · Cited by 38
“Etomoxir treatment of non-autoimmune mice restricts Treg cell differentiation and function without disturbing inflammatory T cell subsets, and the reliance of Treg cells on FAO has been confirmed in vitro [27].”
BackgroundModulation of PKM Activity Controls Differentiation of Th17 Cells
Seki, S. M., Posyniak, K., McCloud, R. L., Rosen, D. A., Fernández-Castañeda, A., Beiter, R. M., Serbulea, V., Nanziri, S. C., Hayes, N. W., Spivey, C., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aay9217 · Cited by 44
Sung, J., & Cheong, J. (2022) · Cells · doi:10.3390/cells11050768 · Cited by 51
“Addition of exogenous FAs to cultures of activated T cells inhibits the production of Th1, Th2, and Th17 cytokines but does not affect Tregs [58].”
BackgroundInfluentialImmunometabolism shapes B cell fate and functions
Fu, Y. L., Wang, L., Yu, B., Xu, D., & Chu, Y. (2022) · Immunology · doi:10.1111/imm.13499 · Cited by 47
Wei, Y., Ding, J., Li, J., Cai, S., Liu, S., Hong, L., Yin, T., Zhang, Y., & Diao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717014 · Cited by 44
Current status and perspectives of regulatory T cell-based therapy
Qu, G., Chen, J., Li, Y., Yuan, Y., Liang, R., & Li, B. (2022) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2022.05.005 · Cited by 44
Iron controls T helper cell pathogenicity by promoting glucose metabolism in autoimmune myopathy
Lai, Y., Zhao, S., Chen, B., Huang, Y., Guo, C., Li, M., Ye, B., Wang, S., Zhang, H., & Yang, N. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.999 · Cited by 38
Metabolic changes during B cell differentiation for the production of intestinal IgA antibody
Kunisawa, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2414-8 · Cited by 40
Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism
Rosa, V. D., Rella, F. D., Giacomo, A. D., & Matarese, G. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.001 · Cited by 39
Regulatory T Cell Metabolism in the Hepatic Microenvironment
Wawman, R. E., Bartlett, H., & Oo, Y. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01889 · Cited by 40
Inflammation research sails through the sea of immunology to reach immunometabolism
Kumar, V. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.002 · Cited by 45
Kunkl, M., Sambucci, M., Ruggieri, S., Amormino, C., Tortorella, C., Gasperini, C., Battistini, L., & Tuosto, L. (2019) · Cells · doi:10.3390/cells8060575 · Cited by 48
“Pro‐inflammatory Th17 cells also utilizes a high rate of glycolysis for sustaining their energy and biosynthetic needs [25,56] and recent data from Shi et al.”
BackgroundMetabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
Gong, Y., Yang, J., Wang, Y., Xue, L., & Wang, J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32990 · Cited by 46
“Glucose deficiency directly suppresses the activation and proliferation of T-cells and induces T-cell anergy and death.40–42 In contrast to the effector T-cells, the Tregs exhibit downregulated glycolysis and rely mainly on the oxidation of fatty acids for energy.43,44 Glucose deficiency promotes the induction of Treg…”
BackgroundTargeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
Penny, H. L., Sieow, J. L., Gun, S. Y., Lau, M. C., Lee, B. T. K., Tan, J., Phua, C., Toh, F., Nga, Y., Yeap, W. H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126350 · Cited by 40
“Th1, Th2, and Th17, but not TReg cells, express high surface levels of GLUT1 alongside elevated rates of glycolysis [25], indicating that GLUT1 is a key player in the metabolic program that drives pro-inflammatory phenotypes.”
BackgroundIdentification of causal metabolites related to multiple autoimmune diseases
Yu, X., Cao, R., Yang, Y., & Lei, S. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab273 · Cited by 43
The interplay between regulatory T cells and metabolism in immune regulation
Zeng, H., & Chi, H. (2013) · OncoImmunology · doi:10.4161/onci.26586 · Cited by 42
“However, the glycolytic rate of Tregs is higher than that of naïve T cells.(64) Compared”
BackgroundZhu, H., Liu, Z., An, J., Zhang, M., Qiu, Y., & Zou, M. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00790-w · Cited by 41
“Stimulation of AMPK in vivo with the AMPK activator metformin increased the number of Treg cells [18], attenuated experimental autoimmune encephalomyelitis (EAE), and suppressed systemic autoimmunity [19, 20].”
BackgroundImmune–Metabolic Interactions and T Cell Tolerance in Pregnancy
Moldenhauer, L. M., Hull, M. L., Foyle, K. L., McCormack, C. D., & Robertson, S. A. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200362 · Cited by 36
Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment
Jin, R., Hao, J., Yu, J., Wang, P., Sauter, E. R., & Li, B. (2023) · Cancers · doi:10.3390/cancers15030657 · Cited by 46
“AMPK activation by a high AMP/ATP ratio, AICAR (5-aminoimidazole-4carboxamide ribonucleotide) or metformin, strongly enhances mitochondrial FAO, thereby promoting the expansion of Tregs [65,95].”
BackgroundMetabolism in type 2 immune responses
Kabat, A. M., Pearce, E. L., & Pearce, E. J. (2023) · Immunity · doi:10.1016/j.immuni.2023.03.007 · Cited by 41
AMPK in Lymphocyte Metabolism and Function
Andris, F., & Léo, O. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.969422 · Cited by 42
“In support of this concept of metabolism-triggered T helper cell differentiation, inhibition of mitochondrial lipid uptake and oxidation has been shown to selectively suppress the development of Tregs, while addition of fatty acids during T cell activation prevents differentiation of Th1, Th2, or Th17 cells while spar…”
BackgroundInfluentialPark, M.-J., Lee, S. H., Lee, S., Lee, E., Kim, E., Choi, J. Y., & Cho, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/631384 · Cited by 43
T lymphocytes against solid malignancies: winning ways to defeat tumours
Caruana, I., Simula, L., Locatelli, F., & Campello, S. (2018) · Cell Stress · doi:10.15698/cst2018.07.148 · Cited by 40
Vukelic, M., Kono, M., & Tsokos, G. C. (2020) · Immunometabolism · doi:10.20900/immunometab20200009 · Cited by 37
“LIPID METABOLISM Fatty acid oxidation (FAO) is a mitochondrial aerobic process responsible for producing acetyl CoA from fatty acids which enters the TCA cycle (Figure 1).”
BackgroundInfluentialZhang, Y., Wang, S., Song, S., Yang, X., & Jin, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01473 · Cited by 37
Wu, H., Herr, D., MacIver, N. J., Rathmell, J. C., & Gerriets, V. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106922 · Cited by 38
“On day 3 post stimulation, cells were split 1:2 and expanded with IL-2 for an additional 2 days (30, 31).”
MethodSelf-citationNam, J. S., Roh, Y. H., Almarzouq, W. F., Noh, H. E., Ha, J., Yoon, J., Kim, C., & Cho, H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047230 · Cited by 43
Lan, R., Wan, Z., Xu, Y., Wang, Z., Fu, S., Zhou, Y., Lin, X., Han, X., Luo, Z., Miao, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696101 · Cited by 37
Metabolic regulation of infection and inflammation
Chauhan, P. S., & Saha, B. (2018) · Cytokine · doi:10.1016/j.cyto.2018.11.016 · Cited by 40
Metabolic rewiring: a new master of Th17 cell plasticity and heterogeneity
Papadopoulou, G., & Xanthou, G. (2021) · FEBS Journal · doi:10.1111/febs.15853 · Cited by 42
Zhang, H., Li, Y., Huang, J., Shen, L., & Yang, X. W. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.07.021 · Cited by 41
“Alterations in lipid metabolism are central to Tregs activation, with pharmacological inhibition of CPT1 restraining Tregs proliferation 126 .”
Chowdhury, N. U., Cephus, J.-Y., Pilier, E. H., Wolf, M. M., Madden, M. Z., Kuehnle, S. N., McKernan, K. E., Jennings, E. Q., Arner, E. N., Heintzman, D. R., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci177242 · Cited by 36
“Once activated, effector CD4 + T cells substantially increase glycolysis to proliferate and undergo clonal expansion (2, 4).”
Self-citationPlasticity within the αβ+CD4+T-cell lineage: when, how and what for?
Coomes, S. M., Pelly, V. S., & Wilson, M. S. (2013) · Open Biology · doi:10.1098/rsob.120157 · Cited by 51
Integrated regulation of the cellular metabolism and function of immune cells in adipose tissue
Oishi, Y., & Manabe, I. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12539 · Cited by 40
“Similarly, overexpression of Glut1 promotes effector T cell differentiation.(35) Inhibition of mitochondrial lipid uptake and oxidation using a creatine palmitoyl-transferase-1 (CPT-1) inhibitor, etomoxir, suppresses Treg differentiation without affecting Teff differentiation, while increasing FAO promotes Treg differ…”
BackgroundMangalam, A. K., Rattan, R., Suhail, H., Singh, J., Hoda, M. N., Deshpande, M., Fulzele, S., Đenić, A., Shridhar, V., Kumar, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501549 · Cited by 34
Pathway analysis of transcriptomic data shows immunometabolic effects of vitamin D
García, A. M., Kutmon, M., Eijssen, L., Hewison, M., Evelo, C. T., & Coort, S. L. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0186 · Cited by 37
Modulating Iron for Metabolic Support of TB Host Defense
Phelan, J. J., Basdeo, S. A., Tazoll, S. C., McGivern, S., Saborido, J. R., & Keane, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02296 · Cited by 40
Piccirillo, A., Hyzny, E. J., Beppu, L. Y., Menk, A. V., Wallace, C. T., Hawse, W. F., Buechel, H. M., Wong, B. H., Foo, J. C., Cazenave‐Gassiot, A., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801585 · Cited by 42
Lipid mediators and asthma: Scope of therapeutics
Monga, N., Sethi, G. S., Kondepudi, K. K., & Naura, A. S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113925 · Cited by 40
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
Coleman, M. F., Cozzo, A. J., Pfeil, A. J., Etigunta, S. K., & Hursting, S. D. (2020) · Cancers · doi:10.3390/cancers12040852 · Cited by 39
“While cytotoxic CD8+ T cell function would be impaired in the low glucose conditions of the TME, T regulatory cells (Tregs), which rely on fatty acid oxidation (FAO) rather than glycolysis, can survive and exert their immunosuppressive effects [16].”
BackgroundLiepinsh, E., Makarova, E., Plakane, L., Konrāde, I., Liepins, K., Ozola, M., Sevostjanovs, E., Grīnberga, S., Makrecka‐Kuka, M., & Dambrova, M. (2020) · Physiological Reports · doi:10.14814/phy2.14489 · Cited by 45
“Mitochondrial fatty acid oxidation was shown to be pivotal for immune cells anti-inflammatory status (Michalek et al., 2011; Vats et al., 2006; Weinberg, Sena, & Chandel, 2015).”
Background
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.